Evaluation of the safety of PD‐1/PD‐L1 inhibitors for immunotherapy in patients with malignant tumors after COVID‐19 infection: A single‐center cohort study
Abstract Introduction An increasing body of evidence suggests a close association between COVID‐19 infection and the safety of PD‐1/PD‐L1 inhibitor therapy in cancer patients. However, the available data concerning these impacts remain limited and occasionally contradictory. Material and Methods We...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70202 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|